These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8267750)

  • 81. Pregnancy associated plasma protein A in Down's syndrome.
    Macintosh MC; Chard T
    BMJ; 1992 Aug; 305(6850):425. PubMed ID: 1382770
    [No Abstract]   [Full Text] [Related]  

  • 82. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
    Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A sonographic sign for fetal Down's syndrome.
    Defoort P; Thiery M
    Am J Obstet Gynecol; 1986 May; 154(5):1169-70. PubMed ID: 2939724
    [No Abstract]   [Full Text] [Related]  

  • 85. Estimating risk of Down's syndrome.
    BMJ; 1991 Jun; 302(6791):1536-7. PubMed ID: 1830232
    [No Abstract]   [Full Text] [Related]  

  • 86. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
    Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
    BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Better quality data for Down's syndrome register.
    Mutton D; Alberman E; Ide R; Bobrow M
    BMJ; 1993 Jun; 306(6891):1541. PubMed ID: 8363658
    [No Abstract]   [Full Text] [Related]  

  • 88. Rapid prenatal diagnosis of Down's syndrome with in-situ hybridisation of fluorescent DNA probes.
    Julien C; Bazin A; Guyot B; Forestier F; Daffos F
    Lancet; 1986 Oct; 2(8511):863-4. PubMed ID: 2876308
    [No Abstract]   [Full Text] [Related]  

  • 89. Down's syndrome screening: where to now?
    Whittle M
    BJOG; 2001 Jun; 108(6):559-61. PubMed ID: 11426887
    [No Abstract]   [Full Text] [Related]  

  • 90. Estimations of gestational age and screening for Down's syndrome.
    Reynolds TM; Penney MD
    BMJ; 1991 May; 302(6786):1207. PubMed ID: 1828380
    [No Abstract]   [Full Text] [Related]  

  • 91. Fluorescent in-situ hybridisation and Down's syndrome.
    Seres-Santamaria A; Catala V; Cuatrecasas E; Villanueva R
    Lancet; 1993 Jun; 341(8859):1544. PubMed ID: 8099427
    [No Abstract]   [Full Text] [Related]  

  • 92. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice.
    Smith DK; Shaw RW; Marteau TM
    BMJ; 1994 Sep; 309(6957):776. PubMed ID: 7950565
    [No Abstract]   [Full Text] [Related]  

  • 93. Counselling needed after screening for Down's syndrome.
    Dennis J; Sawtell M; Rutter S
    BMJ; 1993 Oct; 307(6910):1005. PubMed ID: 8241886
    [No Abstract]   [Full Text] [Related]  

  • 94. Prenatal diagnosis of Down's syndrome.
    Valenti C; Schutta EJ; Kehaty T
    Lancet; 1968 Jul; 2(7561):220. PubMed ID: 4173436
    [No Abstract]   [Full Text] [Related]  

  • 95. Down's syndrome screening.
    Boyd PA; Chamberlain P
    Lancet; 1999 Dec 18-25; 354(9196):2171. PubMed ID: 10609855
    [No Abstract]   [Full Text] [Related]  

  • 96. Antenatal screening for Down's syndrome.
    Bain AD; Sutherland GR
    Lancet; 1973 Feb; 1(7800):423. PubMed ID: 4119726
    [No Abstract]   [Full Text] [Related]  

  • 97. Inadequate prenatal diagnosis of Down's syndrome.
    Harris R
    Br Med J; 1978 Jul; 2(6131):199-200. PubMed ID: 150301
    [No Abstract]   [Full Text] [Related]  

  • 98. Existence and quality of written antenatal screening policies in the United Kingdom: postal survey.
    Lane B; Challen K; Harris HJ; Harris R
    BMJ; 2001 Jan; 322(7277):22-3. PubMed ID: 11141145
    [No Abstract]   [Full Text] [Related]  

  • 99. Prenatal prediction of Down syndrome.
    Reynolds TM; Penney MD
    Am J Obstet Gynecol; 1991 Sep; 165(3):781-2. PubMed ID: 1832525
    [No Abstract]   [Full Text] [Related]  

  • 100. Serum screening for Down's syndrome.
    Dawson AJ; Jones G; Matharu MS; Reynolds TM; Penney MD; John R; Creasy M; Gregory P
    Br J Obstet Gynaecol; 1993 Sep; 100(9):875-7. PubMed ID: 8218019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.